ACAD
ACADIA Pharmaceuticals Inc
NASDAQ: ACAD · HEALTHCARE · BIOTECHNOLOGY
$22.20
-2.07% today
Updated 2026-04-29
Market cap
$3.80B
P/E ratio
9.65
P/S ratio
3.55x
EPS (TTM)
$2.30
Dividend yield
—
52W range
$14 – $28
Volume
1.9M
WallStSmart proprietary scores
63
out of 100
Grade: C+
Hold
Investment rating
8.7
Growth
A6.0
Quality
B8.0
Profitability
A5.7
Valuation
C+3/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$31.70
+42.79%
12-Month target
$21.13
-4.82%
Intrinsic (DCF)
—
Margin of safety
—
4 Strong Buy12 Buy4 Hold1 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Profit margin 36.50% — above average
+ ROE 39.90% — strong efficiency
Risks
- Piotroski 3/9 — weak financial health
- Negative free cash flow $-52.74M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $517.24M | $726.44M | $957.80M | $1.07B | $1.07B |
| Net income | $-215.97M | $-61.29M | $226.45M | $391.00M | $273.57M |
| EPS | — | — | — | — | $2.30 |
| Free cash flow | $-114.03M | $-23.35M | $157.20M | $105.15M | $-52.74M |
| Profit margin | -41.76% | -8.44% | 23.64% | 36.49% | 36.50% |
Peer comparison
Smart narrative
ACADIA Pharmaceuticals Inc trades at $22.20. representing a P/E of 9.65x trailing earnings. Our Smart Value Score of 63/100 indicates the stock is good. The company scores 3/9 on the Piotroski F-Score. TTM revenue stands at $1.07B. with profit margins at 36.50%.
Frequently asked questions
What is ACADIA Pharmaceuticals Inc's stock price?
ACADIA Pharmaceuticals Inc (ACAD) trades at $22.20.
Is ACADIA Pharmaceuticals Inc overvalued?
Smart Value Score 63/100 (Grade C+, Hold).
What is the price target of ACADIA Pharmaceuticals Inc (ACAD)?
The analyst target price is $31.70, representing +42.8% upside from the current price of $22.20.
What is ACADIA Pharmaceuticals Inc's revenue?
TTM revenue is $1.07B.
Piotroski F-Score?
3/9 — weak financial health.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio3.55x
ROE39.90%
Beta0.83
50D MA$22.25
200D MA$23.75
Shares out0.17B
Float0.13B
Short ratio—
Avg volume1.9M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—